Quarterly Earnings

Connection (CNXN) reports a 27.8% surge in Q1 net income driven by enterprise AI adoption, yet faces a steep 31% decline in public sector sales.

Singaporean oil trader Delixy Holdings faces a 180-day deadline to rescue its Nasdaq listing after its stock price collapsed, forcing tough choices.

The company capitalized on geopolitical turmoil and strong demand to post a massive Q1 profit, while advancing its long-term low-carbon ammonia project.

Markel Group reports a Q1 loss due to market volatility, but its core insurance engine shines with a 31% profit jump and improved underwriting.

Benchmark Electronics raises its 2026 forecast after strong Q1 results, driven by sector growth and a successful two-year strategic transformation.

RPC, Inc. adds a former Goldman Sachs MD to its board, a strategic move signaling a focus on sharp capital allocation in the volatile oilfield services sector.

The regional bank posts a stunning $1.1M Q3 profit, driven by aggressive loan growth and a new Wakefield branch, but faces questions on valuation.

Veralto beats earnings expectations and raises its full-year outlook after deploying $1 billion on strategic acquisitions and share repurchases in a strong Q1.

Strong Q1 2026 earnings beat expectations, funding TETRA's strategic move into domestic lithium, bromine, and battery tech amid geopolitical shifts.

George Boedecker Jr., the man behind the iconic foam clog, will release a tell-all book detailing the wild success, personal turmoil, and redemption.

With its Q1 2026 earnings call set for May 13, FinTech firm Usio faces investor scrutiny after a recent earnings miss. Will it deliver on its growth promises?

GreenTree Hospitality's Q4 results show a 25% revenue drop but a surprising 9.2% rise in core net income, signaling tough cost cuts and a cautious 2026.

Taiwanese foundry UMC posts a 108% profit surge, driven by strong 22nm chip demand, a key Intel partnership, and a positive outlook despite global risks.

As DLH Holdings prepares its Q2 results, investors watch to see if it can navigate contract losses and prove its mettle in the federal tech space.

Omnicell appoints Rick Couldry as its first Chief Pharmacy Officer, a strategic move to embed 30 years of real-world hospital experience into its tech.

The trading signal provider is rolling out new automated tools, touting major Q1 gains. But how do its claims stack up in a competitive, skeptical market?

The investment bank reports a 100% revenue surge, raises dividends, and outpaces rivals, signaling a potential renaissance for the entire M&A sector.

With Chili's marking five years of straight growth, parent Brinker International raises its profit outlook and boosts shareholder returns, despite headwinds at Maggiano's.

Despite a weather-induced production dip, Woodside's major projects advance as new CEO Liz Westcott launches a strategic review to boost efficiency.

With a solid 2025 behind them, investors are watching Bioventus's Q1 results for signs of continued momentum in innovation and profitability.